Azienda Ospedaliera San Giovanni Battista
Quick facts
Marketed products
- Fludarabin · Oncology
- lysine acetylsalicylate · Cardiovascular; Pain management; Inflammation
Lysine acetylsalicylate is a salt form of aspirin that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and provide analgesic, anti-inflammatory, and antiplatelet effects.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Azienda Ospedaliera San Giovanni Battista portfolio CI brief
- Azienda Ospedaliera San Giovanni Battista pipeline updates RSS
Frequently asked questions about Azienda Ospedaliera San Giovanni Battista
What are Azienda Ospedaliera San Giovanni Battista's marketed drugs?
Top marketed products include Fludarabin, lysine acetylsalicylate.
Related
- Fludarabin · Oncology
- lysine acetylsalicylate · Cardiovascular; Pain management; Inflammation
- Sector hub: All tracked pharma companies